Georgia Medicare Part D Out-of-Pocket Cap Guide 2026

A Georgia senior on a high-cost prescription used to face drug bills with no ceiling. Since 2025, the Medicare Part D out-of-pocket cap ends that: it limits what you pay for covered Part D drugs to $2,000 in 2025 and $2,100 in 2026, and once you hit it you pay $0 for covered drugs the rest of the year. This guide explains how the cap works, how your spending counts toward it, and how the Medicare Prescription Payment Plan and the rest of the Inflation Reduction Act's Part D redesign protect Georgia beneficiaries and their caregivers.1

How the Georgia Medicare Part D Out-of-Pocket Cap Works

The Medicare Part D out-of-pocket cap is the most you can be required to pay out of pocket for covered prescription drugs in a calendar year. For 2026 that ceiling is $2,100 (it was $2,000 in 2025). Once your covered-drug spending reaches the cap, you pay $0 for covered Part D drugs for the rest of the year.1

Before the Inflation Reduction Act (IRA), Part D had no annual out-of-pocket maximum. The benefit ran through a deductible phase, an initial coverage phase, a coverage gap (the so-called "donut hole"), and a catastrophic phase. Even in the catastrophic phase, beneficiaries kept paying coinsurance on every fill, so a Georgia senior on an expensive oncology, autoimmune, or multiple sclerosis drug could keep paying hundreds or thousands of dollars per fill with no ceiling.

The IRA phased in the protection in three steps:

• January 1, 2024: the catastrophic-phase coinsurance beneficiaries used to owe was eliminated.
• January 1, 2025: a hard $2,000 annual out-of-pocket cap took effect and the donut hole was eliminated.1
• January 1, 2026: the cap rose to $2,100, adjusted for the growth in average Part D drug costs; it continues to adjust each year.1

The cap is one part of a broader, IRA-driven Part D redesign that also includes the Medicare Manufacturer Discount Program, the Medicare Drug Price Negotiation Program, a $35 monthly insulin cap, expanded Extra Help, and the Medicare Prescription Payment Plan. Each is covered below.4

The Part D Benefit Structure After the IRA (2026)

The 2025 redesign collapsed the old four-phase benefit into three phases. In 2026 the standard benefit works like this:

Plans may set a lower deductible than $615, and beneficiaries with full Extra Help have a $0 deductible. The $2,100 cap is the single ceiling that ends cost sharing for the year.3

Why the Georgia Medicare Part D Out-of-Pocket Cap Matters

For Georgia seniors and the family members who help manage their care, the cap changes the math of prescription drug coverage. Many Georgia Medicare beneficiaries take medications that, under the old Part D design, generated thousands of dollars in annual out-of-pocket spending. Now that spending is capped at $2,100 for 2026.1

What that means for different Georgia beneficiaries:

• Beneficiaries without Extra Help get the most direct protection: for the first time, their Part D out-of-pocket spending has a hard annual ceiling.
• Beneficiaries with cancer, autoimmune disease, multiple sclerosis, or other high-cost conditions who once faced open-ended catastrophic-phase spending now stop paying once they hit the cap.
• Dual-eligibles and others with full Extra Help already pay very low fixed copays, so the cap matters less for them day to day, but they are still protected by it and by the wider redesign.
• Caregivers gain a predictable number to plan around: the worst case for a covered Part D drug bill in 2026 is $2,100, and less if the person qualifies for Extra Help.1

The cap also reduces cost-driven medication non-adherence, a common and avoidable cause of hospitalization among seniors, and it pairs with the Medicare Prescription Payment Plan so families can spread that cost evenly across the year.

How the Out-of-Pocket Cap Is Calculated (TrOOP)

The cap counts your True Out-of-Pocket (TrOOP) costs. TrOOP is what you (or certain third parties on your behalf) actually pay toward covered drugs:

• Your deductible payments.
• Your coinsurance and copayments.
• Certain qualifying payments made for you by third parties, such as Extra Help / the Low-Income Subsidy, State Pharmaceutical Assistance Programs, and some charitable programs.

TrOOP does not include your Part D premium, your plan's payments, federal reinsurance, or the cost of drugs that are not on your plan's formulary. Importantly, manufacturer discounts under the Manufacturer Discount Program do not count toward TrOOP. They lower your plan sponsor's liability on the negotiated price rather than what you pay at the counter, and they do not move you closer to the $2,100 cap; only your own payments do.5

The Medicare Prescription Payment Plan (M3P)

The Medicare Prescription Payment Plan, sometimes called M3P, took effect January 1, 2025 and every Part D and MA-PD plan must offer it. It lets you spread your out-of-pocket drug costs into capped monthly payments across the calendar year instead of paying the full amount at the pharmacy. It is free to join and voluntary, and it does not lower your total drug costs; it only changes the timing.2

M3P helps most if you would otherwise hit a large bill early in the year, for example a Georgia senior who reaches the full cap on a single specialty drug in January. Here is how to use it:

The Manufacturer Discount Program

The Medicare Part D Manufacturer Discount Program was added by Section 11201 of the Inflation Reduction Act as Section 1860D-14C of the Social Security Act. It took effect January 1, 2025 and replaced the former Coverage Gap Discount Program, which ran from 2011 to 2024.5

Under the program, manufacturers of applicable drugs (brand-name drugs and biologics covered under a Discount Program agreement with the Centers for Medicare & Medicaid Services) provide a discount at the point of sale: typically 10% in the initial coverage phase and typically 20% in the catastrophic phase. Biosimilars ARE applicable drugs: an applicable drug is a Part D drug approved under a new drug application or, for a biological product, licensed under section 351 of the Public Health Service Act, which is how biosimilars are licensed. Generic drugs approved under an abbreviated new drug application are not. The discount lowers the plan sponsor's liability on the negotiated price rather than reducing what you pay at the counter, and it is excluded from TrOOP, so it does not accelerate you to the $2,100 cap.5

The Insulin Copay Cap

Separate from the out-of-pocket cap, the IRA caps the cost of covered insulin at no more than $35 for a one-month supply of each covered insulin product, with no deductible. Under Part D (IRA Section 11406, since January 1, 2023), the $35 monthly cap applies to every covered insulin your drug plan covers and holds in every coverage phase. Under Part B (IRA Section 11407, since July 1, 2023), insulin used with a traditional insulin pump covered under the durable medical equipment benefit is likewise capped at $35 per month, with no Part B deductible.4

For a Georgia senior with diabetes, this cap applies even before the Part D deductible is met, and it is independent of the broader $2,100 out-of-pocket cap.1

Expanded Extra Help (Low-Income Subsidy)

The IRA also expanded Part D's Extra Help program, also called the Low-Income Subsidy (LIS). Effective January 1, 2024, the former partial-subsidy tier was eliminated, so everyone who qualifies now receives the full subsidy. For 2026, the full-benefit income limit is below 150% of the Federal Poverty Level, about $1,995 per month ($23,940 per year) for an individual.6

Full Extra Help gives a beneficiary a $0 Part D deductible, no more than $5.10 per generic and $12.65 per brand-name covered drug in 2026, and $0 once out-of-pocket drug costs reach the $2,100 threshold. Georgia seniors with modest incomes should apply through the Social Security Administration even if they were turned down before, because the expanded rules bring in people who did not previously qualify.6

How the Cap Plays Out: Georgia Examples

These illustrations show the same 2026 rules applied to different situations. They are examples, not case files, and actual costs depend on your plan and drugs.

A specialty-drug patient who hits the cap early

A 70-year-old in Fulton County is prescribed a high-cost oral oncology drug. In January she pays her plan's deductible, then 25% coinsurance until her spending reaches the $2,100 cap, which a high-priced drug can trigger on the first fill. For the rest of 2026 she pays $0 for covered Part D drugs. She also enrolls in M3P, so instead of paying $2,100 in January she pays capped monthly amounts across the year.1

A dual-eligible with full Extra Help

A 75-year-old in DeKalb County is dual-eligible for Medicare and Georgia Medicaid with full Extra Help. Her copays are already limited to no more than $5.10 per generic and $12.65 per brand-name drug, and her total spending typically stays well below $2,100. For her, the LIS protections matter more than the cap, though the cap still applies.6

A senior on several drugs who reaches the cap mid-year

A 72-year-old in rural Worth County takes eight medications, including one specialty biologic. His generic copays stay low, and his brand-drug coinsurance in the initial coverage phase adds up until his out-of-pocket spending reaches the $2,100 cap partway through the year. From that point on he pays $0 for covered drugs. Because he is not Extra Help eligible, the cap is his main protection, and M3P smooths his payments.1

What Georgia Seniors and Caregivers Should Do

1. Enroll in M3P if you expect high drug costs. Spreading costs across the year makes a large early bill manageable.
2. Compare plans every year during Open Enrollment (October 15 to December 7). GeorgiaCares SHIP counselors can compare plans against your specific drug list for free.
3. Apply for Extra Help if your income is modest. The expanded rules mean many people who were denied before now qualify.
4. Track your out-of-pocket spending. Your plan shows your progress toward the cap on your Explanation of Benefits; once you reach $2,100, you owe $0 for covered drugs.1
5. Use the insulin cap. Your cost for a one-month supply of each covered insulin is capped at $35, even before your deductible.
6. Review your Annual Notice of Change each fall. A drug covered in 2025 may move to a higher tier or off the formulary in 2026.

Common Pitfalls to Avoid

1. Not knowing the cap exists. Many seniors still do not realize their covered-drug costs are capped. A SHIP counselor can confirm how the cap applies to you.
2. Missing an M3P payment. If you do not pay your monthly M3P bill, your plan can remove you from the program for the rest of the year, so budget for the installments.
3. Assuming manufacturer discounts speed you to the cap. They lower your plan sponsor's liability, not your counter price, and they do not count toward your $2,100 TrOOP total.5
4. Overlooking Extra Help. Beneficiaries who qualify under the expanded income limit often do not apply. Check with Social Security.
5. Formulary and prior-authorization surprises. Even with the cap, a plan can require prior authorization or place a specialty drug on an unfavorable tier. Compare plans on your exact drug list during Open Enrollment.
6. Dual-eligible coordination errors. If you have both Medicare and Georgia Medicaid, confirm your status with both so cost-sharing is coordinated correctly.

Georgia Medicare Part D Resources

If you, a family member, or someone you care for is enrolled in Medicare Part D or an MA-PD plan, these contacts can help with cap questions, M3P enrollment, plan comparisons, and Extra Help applications.

Learn More

Find personalized help navigating Medicare Part D in Georgia at brevy.com.

The information on Brevy.com is for educational purposes only and is not a substitute for professional legal, financial, or medical advice. Rules vary by state and program and change frequently. Always verify with the relevant agency or a qualified professional. Brevy is not a law firm, financial advisor, or healthcare provider.